Update on China and India and Access to Medicines

HRC REPORT: This update of the 2004 DFID study explains recent alignments between TRIPS and domestic laws in India and China and the practical implications for access to raw material and finished product supply of important medicines like tenofovir for AIDS and artemisinin combination therapies for malaria.


file type iconDOWNLOAD [567 KB]

Leave a Reply

Your email address will not be published. Required fields are marked *

file type iconDOWNLOAD [567 KB]